Avoro Capital Advisors’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Avoro Capital Advisors’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-70,000	Closed	-$1.12M	–	55
2016 Q2	$1.12M	Sell	70,000 -141,672	-67%	-$2.54M	0.25%	35
2016 Q1	$4.43M	Sell	211,672 -572,527	-73%	-$10.2M	1.54%	19
2015 Q4	$21.2M	Sell	784,199 -20,100	-2%	-$548K	7.29%	4
2015 Q3	$22.4M	Buy	804,299 +192,300	+31%	+$6.06M	5.81%	5
2015 Q2	$15M	Buy	611,999 +150,500	+33%	+$3.1M	4.13%	9
2015 Q1	$8.45M	Buy	461,499 +215,000	+87%	+$4.36M	3.24%	10
2014 Q4	$4.55M	Buy	+246,499	New	+$2.93M	3.08%	11

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Avoro Capital Advisors's LJPC Position: Q3 2016 in Review

Avoro Capital Advisors sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2016, closing a stake of 70,000 shares — an estimated $1.12M sold.

Avoro Capital Advisors first reported a position in LJPC in Q4 2014 and held it in 7 quarters. The position peaked at $22.4M in Q3 2015. 71 funds tracked by Wall St. Rank hold LJPC as of Q3 2016.

Avoro Capital Advisors reported no remaining La Jolla Pharmaceutical Company position as of Q3 2016 after selling out during the quarter.
Avoro Capital Advisors sold 70,000 La Jolla Pharmaceutical Company shares in Q3 2016, an estimated $1.12M.
Avoro Capital Advisors first reported a position in La Jolla Pharmaceutical Company in Q4 2014 and held it in 7 quarters.
Avoro Capital Advisors's La Jolla Pharmaceutical Company position peaked at $22.4M in Q3 2015.
71 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2016.

Based on Avoro Capital Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.